dihexa c-met cancer risk Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck | Molecular Cancer Dihexa Peptide: Benefits, Mechanism, and

& Tschop, M

How long do I have to commit to the program

Potential Use Cases Dihexa is for research and physician-supervised use only

The peptide's effects on growth factor signaling and vascular function may theoretically interact with certain medications affecting these pathways

Unknown long-term profile: Human safety data is limited, so caution and monitoring are advised

Figure 1: Changes in body weight from baseline to the end of treatment at week 26 associated with the trial product estimand, in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo